Mr. DeMartino will step into his role Sept. 9 and will develop, refine and lead the company’s investor relations strategy. He has more than 25 years of experience in the healthcare industry and was most recently chief strategy officer at Nyxoah.
Mr. DeMartino also has experience working in private company investments, sell-side equity research and medical devices.
“His impressive career achievements and extensive knowledge of the medtech industry, as both an investor and in equity research, make him the ideal candidate for this strategically important position,” CEO Ivan Tornos said in the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
